Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership

finance8.0

Twist Bioscience has partnered with Eli Lilly's TuneLab platform to expand its AI-driven drug discovery capabilities, contributing antibody sequence data to help train Lilly's machine learning models. In exchange, Twist

Read full story at finance →